Tenderwize
Back to tender search

Open-house discount agreement for Sorafenib

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Sep 05, 2026 · 20 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Sorafenib, ATC L01EX02

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

46 / 100

Complexity

58 / 100

Risk factors

The buyer explicitly states this is an open-house model and not a standard competitive procurement procedure, so the us...

Submission requires either handwritten originals in duplicate or a qualified electronic signature via DTVP; incorrect f...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Oct 2026
  • Non-exclusive open-house discount agreements for the medicinal product Sorafenib, ATC L01EX02.
  • Supply-related pharmaceutical contract under German social law framework stated by the buyer.
Show full summary

This is an open-house supply arrangement for pharmaceutical discount agreements on Sorafenib (ATC L01EX02) by AOK Bayern. It is not a competitive award procedure in the usual sense: the buyer states that all interested pharmaceutical companies meeting the stated eligibility condition can join on identical, non-negotiable terms. The contract period runs from 01.11.2024 to 31.10.2026, with contract entry possible until 05.09.2026. Submission can be by handwritten paper originals or by qualified electronic signature via DTVP. No contract value is stated.

Risks

The buyer explicitly states this is an open-house model and not a standard competitive procurement procedure, so the us...

Submission requires either handwritten originals in duplicate or a qualified electronic signature via DTVP; incorrect f...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be completed and signed.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house discount agreement for Sorafenib

Single lot for non-exclusive open-house pharmaceutical discount agreements concerning Sorafenib (ATC L01EX02). The buyer states that identical, non-individually negotiable contracts are offered to all interested pharmaceutical companies meeting the eligibility condition. Performance is in Germany, Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Oct 2024 - Oct 2026

Category

Pharmaceutical products

Deadline

Deadline Sep 05, 2026

Procurement Details

Publication date
16 Sep 2024
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
557828-2024

Documents (2)

Similar tenders